How Sites Manage Pediatric Gene Therapy Trials

By Claire Booth, M.B.B.S., F.R.C.P.C.H., M.Sc., Ph.D.

Pediatric gene therapy trials for rare diseases are among the most complex studies to execute, placing extraordinary demands on clinical trial sites. From intensive regulatory oversight to long‑term follow‑up and family‑centered care, success depends on far more than clinical expertise alone. In this article, an experienced academic investigator shares practical insights from one of Europe’s leading pediatric gene therapy sites. Key themes include:

• The importance of stable, multidisciplinary site teams
• The operational burden of frequent protocol amendments
• Monitoring visits
• The value of dedicated project and data management expertise.

By highlighting the realities faced by sites, this perspective underscores the importance of thoughtful trial design and sponsor‑site collaboration for pediatric patients.